September 11, 2019

Using the “window of opportunity” to understand biomarkers and tumour biology

OICR researchers have recently teamed up with a team of medical oncologists and surgeons at The Ottawa Hospital to launch a new breast cancer clinical trial – one that begins before a patient undergoes surgery. 

“There’s a gap between when a patient is diagnosed with cancer and the start of their surgery,” explains Dr. Melanie Spears, trial co-investigator and Principal Research Scientist at OICR. “A window of opportunity study allows us to use this gap to look at novel targeted therapies.”